← Evidence map

SynthesisOntario health technology assessment series2023

Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

Ontario Health (Quality)PubMed ↗Full text ↗

No numbers read from the abstract.

9 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37637488